Achieving a Complete Molecular Remission Under Imatinib Therapy Is Associated with a Better Outcome in Chronic Phase Chronic Myeloid Leukaemia Patients On Imatinib Frontline Therapy

被引：0
|
作者：
Etienne, Gabriel [8 ]
Nicolini, Nicolini E. [1 ]
Dulucq, Stephanie
Schmitt, Anna [8 ]
Hayette, Sandrine
Lippert, Eric [2 ]
Tigaud, Isabelle [3 ]
Morisset, Stephane [4 ]
Bureau, Caroline [5 ]
Adiko, Didier [6 ]
Marit, Gerald [7 ]
Reiffers, Josy [8 ]
Mahon, Francois-Xavier [9 ]
机构：
[1] Univ Lyon 1, Hop Edouard Herriot, HCL, F-69365 Lyon, France
[2] Ctr Hosp Univ, Lab Hematol, Bordeaux, France
[3] Ctr Hosp Lyon Sud, Lab Mol Biol & Cytogenet, F-69310 Pierre Benite, France
[4] Ctr Hosp Lyon Sud, Dept Hematol, F-69310 Pierre Benite, France
[5] Polyclin Bordeaux Nord Aquitaine, Bordeaux, France
[6] Hop Robert Boulin, Libourne, France
[7] CHU, Serv Hematol Clin & Therapie Cellulaire, Pessac, France
[8] Univ Victor Segalen Bordeaux, Inst Bergonie, Bordeaux, France
[9] CHU Bordeaux, Dept Hematol, Hop Pellegrin, INSERM 1035, Bordeaux, France
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3754.3754
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3754
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Significant weight gain in patient with chronic myeloid leukaemia treated with imatinib therapy
    Milojkovic, D.
    Aduwa, E.
    Szydlo, R.
    Marin, D.
    Reid, A.
    Foroni, L.
    Bua, M.
    Rezvani, K.
    Khorashad, J.
    Goldman, J.
    Apperley, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 84 - 84
  • [42] Nilotinib against high dose imatinib for salvage therapy of chronic myeloid leukaemia
    Soverini, Simona
    Baccarani, Michele
    Martinelli, Giovanni
    LANCET HAEMATOLOGY, 2016, 3 (12): : E554 - E555
  • [43] Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation
    Orsolic, N
    Giles, FJ
    Gourdeau, H
    Golemovic, M
    Beran, M
    Cortes, J
    Freireich, EJ
    Kantarjian, H
    Verstovsek, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (06) : 727 - 738
  • [44] Long Term Adherence to Imatinib Therapy is the Critical Factor for Achieving Molecular Responses in Chronic Myeloid Leukemia Patients
    Bazeos, Alex
    Khorashad, Jamshid
    Mahon, Francois-Xavier
    Eliasson, Lina L.
    Milojkovic, Dragana
    Bua, Marco
    Apperley, Jane
    Szydlo, Richard
    Kozlowski, Kasia
    Paliompeis, Christos
    Desai, Ritti
    Foroni, Letizia
    Reid, Alistair
    de Lavallade, Hugues
    Rezvani, Katy
    Goldman, John
    Marin, David
    BLOOD, 2009, 114 (22) : 1274 - 1275
  • [45] Antituberculosis therapy and imatinib for chronic myeloid leukemia
    Sora, Federica
    De Matteis, Silvia
    Di Mario, Antonella
    Maiuro, Giuseppe
    Laurenti, Luca
    Chiusolo, Patrizia
    Ardito, Fausta
    Leone, Giuseppe
    Sica, Simona
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) : 1223 - 1224
  • [46] Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
    Mahon, Francois-Xavier
    Rea, Delphine
    Guilhot, Joelle
    Guilhot, Francois
    Huguet, Francoise
    Nicolini, Franck
    Legros, Laurence
    Charbonnier, Aude
    Guerci, Agnes
    Varet, Bruno
    Etienne, Gabriel
    Reiffers, Josy
    Rousselot, Philippe
    LANCET ONCOLOGY, 2010, 11 (11): : 1029 - 1035
  • [47] Therapy with Imatinib Mesylate for Chronic Myeloid Leukemia
    Arora, Brijesh
    Kumar, Lalit
    Kumari, Mamta
    Sharma, Atul
    Wadhawa, Jyoti
    Kochupillai, V
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2005, 26 (02) : 5 - +
  • [48] Sustained Complete Molecular Remission after Imatinib Discontinuation in Children with Chronic Myeloid Leukemia
    Moser, Olga
    Krumbholz, Manuela
    Thiede, Christian
    Tauer, Josephine T.
    Janz, Indra
    Lauten, Melchior
    Dilloo, Dagmar
    Metzler, Markus
    Suttorp, Meinolf
    PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2080 - 2082
  • [49] Clinical significance of molecular monitoring in chronic myeloid leukemia (CML) in chronic phase (CP) with imatinib therapy
    Cortes, J
    Talpaz, M
    O'Brien, S
    Jones, D
    Luthra, R
    Garcia-Manero, G
    Giles, F
    Shan, J
    Verstovsek, S
    Rios, MB
    Kantarjian, H
    BLOOD, 2004, 104 (11) : 81A - 81A
  • [50] PREGNANCY AMONG THE PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB THERAPY
    Chelysheva, E. Y.
    Turkina, A. G.
    Gusarova, G. A.
    Kolosheinova, T. I.
    Sokolova, M. A.
    Khoroshko, N. D.
    Pepelyaeva, V. M.
    Gavrilova, L. V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 262 - 262
12345